CIK 0002007919 · <br>Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990613523
- Phone
- (858) 795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- SEC STAFF ACTION Other SEC Staff Action
- CERT Other Certification
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-12B/A Other 10-12B/A
- 10-12B/A Other 10-12B/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-12B Other 10-12B
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
Page 8 of 8 · 158 filings